Risk of heart failure after community acquired pneumonia: Prospective controlled study with 10 years of follow-up

BMJ (Online)

Volumn 356, Issue , 2017, Pages

  Eurich, Dean T ^a   Marrie, Thomas J ^b   Minhas Sandhu, Jasjeet K ^a   Majumdar, Sumit R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITAL CARE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; VERY ELDERLY; AGE; CANADA; COMMUNITY-ACQUIRED INFECTIONS; HEALTH SERVICE; HOSPITAL DISCHARGE; HOSPITALIZATION; MIDDLE AGED; PNEUMONIA; SEVERITY OF ILLNESS INDEX; STANDARDS; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS;

ADULT; AGE FACTORS; AGED; CANADA; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HEART FAILURE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PATIENT DISCHARGE; PNEUMONIA; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 85012922992     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.j413     Document Type: Article

References (37)

1. Eurich DT, Marrie TJ, Minhas-Sandhu JK, Majumdar SR. Ten-Year Mortality after Community-acquired Pneumonia. A Prospective Cohort. Am J Respir Crit Care Med 2015;192:597-604. doi:10.1164/rccm.201501-0140O.C.
2. Huang SS, Johnson KM, Ray GT, et al. Healthcare utilization and cost of pneumococcal disease in the United States. Vaccine 2011;29:3398-412. doi:10.1016/j.vaccine.2011.02.088.
3. Marrie TJ, Wu L. Factors influencing in-hospital mortality in community-acquired pneumonia: a prospective study of patients not initially admitted to the ICU. Chest 2005;127:1260-70. doi:10.1378/chest.127.4.1260.
4. McAlister FA, Majumdar SR, Blitz S, Rowe BH, Romney J, Marrie TJ. The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care 2005;28:810-5. doi:10.2337/diacare.28.4.810.
5. Wang Y, Eldridge N, Metersky ML, et al. National trends in patient safety for four common conditions, 2005-2011. N Engl J Med 2014;370:341-51. doi:10.1056/NEJMsa1300991.
6. Corrales-Medina VF, Musher DM, Wells GA, Chirinos JA, Chen L, Fine MJ. Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation 2012;125:773-81. doi:10.1161/CIRCULATIONAHA.111.040766.
7. Corrales-Medina VF, Alvarez KN, Weissfeld LA, et al. Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. JAMA 2015;313:264-74. doi:10.1001/jama.2014.18229.
8. Cabré M, Serra-Prat M, Force L, Palomera E, Pallarés R. Functional status as a risk factor for mortality in very elderly patients with pneumonia. Med Clin (Barc) 2008;131:167-70. doi:10.1157/13124262.
9. Aliberti S, Ramirez JA. Cardiac diseases complicating communityacquired pneumonia. Curr Opin Infect Dis 2014;27:295-301. doi:10.1097/QCO.0000000000000055.
10. Viasus D, Garcia-Vidal C, Manresa F, Dorca J, Gudiol F, Carratalà J. Risk stratification and prognosis of acute cardiac events in hospitalized adults with community-acquired pneumonia. J Infect 2013;66:27-33. doi:10.1016/j.jinf.2012.09.003.
11. Fine MJ, Stone RA, Singer DE, et al. Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study. Arch Intern Med 1999;159:970-80. doi:10.1001/archinte.159.9.970.
12. Marrie TJ, Durant H, Yates L. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis 1989;11:586-99. doi:10.1093/clinids/11.4.586.
13. Esposito AL. Community-acquired bacteremic pneumococcal pneumonia. Effect of age on manifestations and outcome. Arch Intern Med 1984;144:945-8. doi:10.1001/archinte.1984.00350170081016.
14. Janssens JP, Gauthey L, Herrmann F, Tkatch L, Michel JP. Communityacquired pneumonia in older patients. J Am Geriatr Soc 1996;44:539-44. doi:10.1111/j.1532-5415.1996.tb01439.x.
15. Fernández-Sabé N, Carratalà J, Rosón B, et al. Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes. Medicine (Baltimore) 2003;82:159-69. doi:10.1097/01.md.0000076005.64510.87.
16. Musher DM, Rueda AM, Kaka AS, Mapara SM. The association between pneumococcal pneumonia and acute cardiac events. Clin Infect Dis 2007;45:158-65. doi:10.1086/518849.
17. Becker T, Moldoveanu A, Cukierman T, Gerstein HC. Clinical outcomes associated with the use of subcutaneous insulin-by-glucose sliding scales to manage hyperglycemia in hospitalized patients with pneumonia. Diabetes Res Clin Pract 2007;78:392-7. doi:10.1016/j.diabres.2007.05.003.
18. Adamuz J, Viasus D, Jiménez-Martínez E, et al. Incidence, timing and risk factors associated with 1-year mortality after hospitalization for community-acquired pneumonia. J Infect 2014;68:534-41. doi:10.1016/j.jinf.2014.02.006.
19. Yende S, Angus DC, Ali IS, et al. Influence of comorbid conditions on long-term mortality after pneumonia in older people. J Am Geriatr Soc 2007;55:518-25. doi:10.1111/j.1532-5415.2007.01100.x.
20. Schembri S, Williamson PA, Short PM, et al. Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies. BMJ 2013;346:f1235. doi:10.1136/bmj.f1235.
21. Mortensen EM, Halm EA, Pugh MJ, et al. Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia. JAMA 2014;311:2199-208. doi:10.1001/jama.2014.4304.
22. Corrales-Medina VF, Suh KN, Rose G, et al. Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies. PLoS Med 2011;8:e1001048. doi:10.1371/journal.pmed.1001048.
23. Corrales-Medina VF, Taljaard M, Fine MJ, et al. Risk stratification for cardiac complications in patients hospitalized for communityacquired pneumonia. Mayo Clin Proc 2014;89:60-8. doi:10.1016/j.mayocp.2013.09.015.
24. Perry TW, Pugh MJ, Waterer GW, et al. Incidence of cardiovascular events after hospital admission for pneumonia. Am J Med 2011;124:244-51. doi:10.1016/j.amjmed.2010.11.014.
25. Corrales-Medina VF, Taljaard M, Yende S, et al. Intermediate and long-term risk of new-onset heart failure after hospitalization for pneumonia in elderly adults. Am Heart J 2015;170:306-12. doi:10.1016/j.ahj.2015.04.028.
26. Díaz A, Alvarez M, Callejas C, Rosso R, Schnettler K, Saldías F. [Clinical picture and prognostic factors for severe community-acquired pneumonia in adults admitted to the intensive care unit]. Arch Bronconeumol 2005;41:20-6. doi:10.1016/S1579-2129(06)60390-X.
27. Menéndez R, Torres A, Zalacaín R, et al. Neumofail Group. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax 2004;59:960-5. doi:10.1136/thx.2003.017756.
28. Querol-Ribelles JM, Tenías JM, Querol-Borrás JM, et al. Levofloxacin versus ceftriaxone plus clarithromycin in the treatment of adults with community-acquired pneumonia requiring hospitalization. Int J Antimicrob Agents 2005;25:75-83. doi:10.1016/j.ijantimicag.2004.07.013.
29. Corrales-Medina VF, Madjid M, Musher DM. Role of acute infection in triggering acute coronary syndromes. Lancet Infect Dis 2010;10:83-92. doi:10.1016/S1473-3099(09)70331-7.
30. Bazaz R, Marriott HM, Francis SE, Dockrell DH. Mechanistic links between acute respiratory tract infections and acute coronary syndromes. J Infect 2013;66:1-17. doi:10.1016/j.jinf.2012.09.009.
31. Yende S, D'Angelo G, Mayr F, et al. GenIMS Investigators. Elevated hemostasis markers after pneumonia increases one-year risk of all-cause and cardiovascular deaths. PLoS One 2011;6:e22847. doi:10.1371/journal.pone.0022847.
32. Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK, Feagan BG. A controlled trial of a critical pathway for treatment of communityacquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA 2000;283:749-55. doi:10.1001/jama.283.6.749.
33. Quan H, Li B, Saunders LD, et al. IMECCHI Investigators. Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database. Health Serv Res 2008;43:1424-41. doi:10.1111/j.1475-6773.2007.00822.x.
34. So L, Evans D, Quan H. ICD-10 coding algorithms for defining comorbidities of acute myocardial infarction. BMC Health Serv Res 2006;6:161. doi:10.1186/1472-6963-6-161.
35. Udris EM, Au DH, McDonell MB, et al. Comparing methods to identify general internal medicine clinic patients with chronic heart failure. Am Heart J 2001;142:1003-9. doi:10.1067/mhj.2001.119130.
36. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94:496-509doi:10.1080/01621459.1999.10474144.
37. Van Eeden S, Leipsic J, Paul Man SF, Sin DD. The relationship between lung inflammation and cardiovascular disease. Am J Respir Crit Care Med 2012;186:11-6. doi:10.1164/rccm.201203-0455PP.